Now live: European new issue coverage and historical data, for free. → Explore All Content & Delivery Channels
Log In
No results found for "".

Commentary & Deal Flow

NEW ISSUE: Oriflame E709m (US$/EUR) fixed/floating sr sec notes on the road

HYC US Market: Deal Flow - GeneralHYC European Market: Deal Flow - General

Oriflame Investment Holding Plc EUR709m equivalent (US$/EUR) 144A/Reg S sr sec notes 2-part. Expect B1/B+/BB-. Via GS/SEB jt glocos and physical books/HSBC jt books, ING as co-manager. List ISE, NY law. No reg rights.

    - USD550m expected size fixed-rate notes due 2026 (5y). NC2 (MWC T+50bp) (50%,25%,par). Equity claw: 2y: 40%. IPT: mid 5% area.

    - EUR250m expected size FRN due 2026 (5y). NC1 (MWC B+50bp) (101,par). IPT: E+450-475bp.

Roadshow today-Weds (investor call at 2pm UKT today). UOP: along with EUR96m cash on hand, to redeem EUR797m existing notes (EUR475m euro notes, plus EUR24m MWC premium and US$335m dollar notes , plus USD22.1m MWC premium).  Biz: international direct selling of beauty products.  HQ: Schaffhausen, Switzerland.

We use functional cookies to make this site work properly and marketing cookies to personalize content. By continuing or clicking "Ok", you consent to our use of cookies. See our Cookie Policy for more information.
By continuing, you agree to FINSIGHT's Terms of Use and Privacy Policy.